Brokers Offer Predictions for Healthequity Inc’s FY2018 Earnings (HQY)

Healthequity Inc (NASDAQ:HQY) – Cantor Fitzgerald dropped their FY2018 earnings per share (EPS) estimates for shares of Healthequity in a research report issued to clients and investors on Wednesday. Cantor Fitzgerald analyst S. Halper now anticipates that the company will post earnings of $0.65 per share for the year, down from their previous forecast of $0.67. Cantor Fitzgerald currently has a “Buy” rating and a $56.00 target price on the stock.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The company had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. During the same quarter in the prior year, the business posted $0.10 earnings per share. The company’s revenue for the quarter was up 31.0% compared to the same quarter last year.

HQY has been the subject of several other research reports. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price target for the company in a research note on Wednesday, October 11th. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research note on Thursday, September 28th. Robert W. Baird reissued a “hold” rating on shares of Healthequity in a research note on Thursday, September 21st. Oppenheimer reissued a “buy” rating and issued a $61.00 price target on shares of Healthequity in a research note on Wednesday, September 6th. Finally, Chardan Capital upped their price objective on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a report on Wednesday, December 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $58.33.

Healthequity (NASDAQ:HQY) traded up $0.78 during trading hours on Monday, hitting $44.54. The stock had a trading volume of 520,812 shares, compared to its average volume of 533,107. Healthequity has a 12 month low of $37.62 and a 12 month high of $55.31. The company has a market capitalization of $2,650.79, a PE ratio of 62.41, a price-to-earnings-growth ratio of 1.81 and a beta of 1.74.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Alps Advisors Inc. lifted its stake in Healthequity by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 10,729 shares of the company’s stock worth $535,000 after acquiring an additional 28 shares in the last quarter. Albion Financial Group UT lifted its stake in Healthequity by 1.4% in the 2nd quarter. Albion Financial Group UT now owns 8,694 shares of the company’s stock worth $433,000 after acquiring an additional 120 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its stake in Healthequity by 7.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after acquiring an additional 191 shares in the last quarter. Arizona State Retirement System lifted its stake in Healthequity by 0.9% in the 2nd quarter. Arizona State Retirement System now owns 23,097 shares of the company’s stock worth $1,151,000 after acquiring an additional 200 shares in the last quarter. Finally, Suntrust Banks Inc. lifted its stake in Healthequity by 2.7% in the 2nd quarter. Suntrust Banks Inc. now owns 9,408 shares of the company’s stock worth $468,000 after acquiring an additional 250 shares in the last quarter. 98.60% of the stock is owned by institutional investors and hedge funds.

In other news, major shareholder Berkley Capital, Llc sold 1,100 shares of the company’s stock in a transaction on Monday, October 9th. The stock was sold at an average price of $51.95, for a total transaction of $57,145.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Frank Medici sold 700 shares of the company’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $51.05, for a total value of $35,735.00. Following the sale, the director now directly owns 6,381 shares of the company’s stock, valued at $325,750.05. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,743,212 shares of company stock valued at $91,145,351. Insiders own 19.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Brokers Offer Predictions for Healthequity Inc’s FY2018 Earnings (HQY)” was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://sportsperspectives.com/2017/12/13/brokers-offer-predictions-for-healthequity-incs-fy2018-earnings-hqy.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply